SCHEMBL196295

SCHEMBL196295

CN(C)c1cccc2c(S(=O)(=O)c3cccc4c3[nH]c3ccccc34)cccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.52
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTT P42858 1/20 0.48
HIF1A Q16665 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
PARP14 Q460N5 3/20 0.47
F2 P00734 3/20 0.46
PRSS1 P07477 3/20 0.46
PRSS2 P07478 3/20 0.46
PRSS3 P35030 3/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
KDM4E B2RXH2 1/20 0.44
NSD2 O96028 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
EDNRA P25101 4/20 0.44
KIF11 P52732 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9633784 0.84 KIF11 (0.53) CYP1A2HTTTDP1PARP14KMT2A
SCHEMBL18669851 0.78 CA2 (0.63) CA2CYP1A2CYP2C19HTTHIF1A
SCHEMBL20887130 0.77 KIF11 (0.58) CYP1A2PARP14KMT2AKDM4ETSHR
SCHEMBL27613656 0.76 CA2 (0.64) CA2CYP1A2CYP2C19HTTHIF1A
SCHEMBL11127453 0.76 CA2 (0.64) CA2CYP1A2CYP2C19HTTHIF1A
SCHEMBL28234384 0.75 FEN1 (0.57) CYP1A2PARP14KMT2AKDM4ETSHR
SCHEMBL28851832 0.73 FEN1 (0.59) CYP1A2L3MBTL1PARP14KMT2AKDM4E
SCHEMBL636439 0.73 CA2 (0.69) CA2CYP1A2CYP2C19HTTHIF1A
SCHEMBL329710 0.73 KIF11 (0.52) CYP1A2HTTTDP1PARP14KMT2A
SCHEMBL17294738 0.72 CA2 (0.55) CA2CYP1A2CYP2C19HTTHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102186820-B Fluorescent regulators of rassf1a expression and human cancer cell proliferation UNIV GEORGETOWN 2013-08-28 CN claimed
EP-2323982-B1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION UNIV GEORGETOWN (US) 2012-02-29 EP claimed
JP-2012500197-A 2012-01-05 JP claimed
CN-102186820-A Fluorescent regulators of rassf1a expression and human cancer cell proliferation UNIV GEORGETOWN 2011-09-14 CN claimed
US-20110152339-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY 2011-06-23 US claimed
EP-2323982-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION Georgetown University (US) 2011-05-25 EP claimed
WO-2010019271-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY (US) 2010-02-18 WO claimed
US-10457639-B2 Fluorescent regulators of RASSF1A expression and human cancer cell proliferation GEORGETOWN UNIVERSITY (US) 2019-10-29 US disclosed
US-10457639-B2 Fluorescent regulators of RASSF1A expression and human cancer cell proliferation GEORGETOWN UNIVERSITY (US) 2019-10-29 US disclosed
US-8637679-B2 Process for the isolation of organic compounds useful for the treatment of cancer COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-01-28 US disclosed
CN-102186820-B Fluorescent regulators of rassf1a expression and human cancer cell proliferation UNIV GEORGETOWN 2013-08-28 CN disclosed
CN-102186820-B Fluorescent regulators of rassf1a expression and human cancer cell proliferation UNIV GEORGETOWN 2013-08-28 CN disclosed
US-20130065932-A1 PROCESS FOR THE ISOLATION OF ORGANIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-03-14 US disclosed
US-20110152339-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY 2011-06-23 US disclosed
US-20110152339-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY 2011-06-23 US disclosed
EP-2323982-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION Georgetown University (US) 2011-05-25 EP disclosed
EP-2323982-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION Georgetown University (US) 2011-05-25 EP disclosed
WO-2010019271-A8 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY (US) 2011-03-31 WO disclosed
WO-2010019271-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY (US) 2010-02-18 WO disclosed
WO-2010019271-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION GEORGETOWN UNIVERSITY (US) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152339-A1 FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION RASSF5, RASSF2, MKI67 CA2 3199/4885CYP1A2 3607/4885CYP2C19 3781/4885
US-20130065932-A1 PROCESS FOR THE ISOLATION OF ORGANIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER PSMG3, HSP90B1, HSPA1A CA2 3567/4885CYP1A2 1411/4885CYP2C19 2542/4885
US-10457639-B2 Fluorescent regulators of RASSF1A expression and human cancer cell proliferation RASSF5, RASSF2, MKI67 CA2 3199/4885CYP1A2 3607/4885CYP2C19 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.